Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionOral mu opioid receptor (OPRM1; MOR) agonist
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat moderate to severe chronic pain; Treat osteoarthritis (OA) knee pain
Regulatory Designation U.S. - Fast Track (Treat chronic pain)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today